Trevi Therapeutics Stock Price Patterns
| TRVI Stock | USD 11.10 0.36 3.14% |
Momentum 46
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.11) | EPS Estimate Current Year (0.36) | EPS Estimate Next Year (0.45) | Wall Street Target Price 21.5455 | EPS Estimate Current Quarter (0.10) |
Using Trevi Therapeutics hype-based prediction, you can estimate the value of Trevi Therapeutics from the perspective of Trevi Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Trevi Therapeutics using Trevi Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Trevi using crowd psychology based on the activity and movement of Trevi Therapeutics' stock price.
Trevi Therapeutics Short Interest
A significant increase or decrease in Trevi Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Trevi. Short interest can provide insight into the potential direction of Trevi Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 8.9564 | Short Percent 0.1395 | Short Ratio 10.28 | Shares Short Prior Month 14.1 M | 50 Day MA 11.9426 |
Trevi Therapeutics Hype to Price Pattern
Investor biases related to Trevi Therapeutics' public news can be used to forecast risks associated with an investment in Trevi. The trend in average sentiment can be used to explain how an investor holding Trevi can time the market purely based on public headlines and social activities around Trevi Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Trevi Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Trevi Therapeutics.
Trevi Therapeutics Implied Volatility | 1.6 |
Trevi Therapeutics' implied volatility exposes the market's sentiment of Trevi Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Trevi Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Trevi Therapeutics stock will not fluctuate a lot when Trevi Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Trevi Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Trevi because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Trevi Therapeutics after-hype prediction price | USD 11.46 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Trevi contract
Based on the Rule 16, the options market is currently suggesting that Trevi Therapeutics will have an average daily up or down price movement of about 0.1% per day over the life of the 2026-04-17 option contract. With Trevi Therapeutics trading at USD 11.1, that is roughly USD 0.0111 . If you think that the market is fully incorporating Trevi Therapeutics' daily price movement you should consider acquiring Trevi Therapeutics options at the current volatility level of 1.6%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Trevi Therapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Trevi Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trevi Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Trevi Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Trevi Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Trevi Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Trevi Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Trevi Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Trevi Therapeutics' historical news coverage. Trevi Therapeutics' after-hype downside and upside margins for the prediction period are 7.30 and 15.62, respectively. We have considered Trevi Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Trevi Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Trevi Therapeutics is based on 3 months time horizon.
Trevi Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Trevi Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Trevi Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Trevi Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.05 | 4.14 | 0.02 | 0.01 | 7 Events / Month | 6 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
11.10 | 11.46 | 0.00 |
|
Trevi Therapeutics Hype Timeline
Trevi Therapeutics is at this time traded for 11.10. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.01. Trevi is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at -0.05%. %. The volatility of related hype on Trevi Therapeutics is about 3312.0%, with the expected price after the next announcement by competition of 11.11. About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.37. Trevi Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Trevi Therapeutics Basic Forecasting Models to cross-verify your projections.Trevi Therapeutics Related Hype Analysis
Having access to credible news sources related to Trevi Therapeutics' direct competition is more important than ever and may enhance your ability to predict Trevi Therapeutics' future price movements. Getting to know how Trevi Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Trevi Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ARDX | Ardelyx | (0.11) | 9 per month | 3.02 | 0.07 | 8.50 | (5.04) | 25.22 | |
| WVE | Wave Life Sciences | 0.74 | 8 per month | 4.09 | 0.09 | 6.72 | (6.18) | 164.47 | |
| NVAX | Novavax | (0.51) | 9 per month | 3.14 | 0.01 | 6.10 | (5.54) | 26.98 | |
| ZBIO | Zenas BioPharma Common | 1.47 | 9 per month | 0.00 | (0.01) | 9.05 | (11.66) | 68.95 | |
| UPB | Upstream Bio | (0.06) | 8 per month | 4.19 | 0.02 | 7.84 | (5.57) | 24.37 | |
| TRML | Tourmaline Bio | 0.01 | 4 per month | 0.00 | 0.16 | 6.53 | (2.70) | 58.54 | |
| TERN | Terns Pharmaceuticals | (1.59) | 10 per month | 2.49 | 0.24 | 8.83 | (5.57) | 43.41 | |
| ZYME | Zymeworks Common Stock | 0.76 | 11 per month | 2.90 | 0.06 | 5.40 | (4.72) | 36.09 | |
| PGEN | Precigen | (0.1) | 10 per month | 4.66 | 0.02 | 7.57 | (7.08) | 38.64 | |
| ORIC | Oric Pharmaceuticals | 0.64 | 9 per month | 0.00 | (0.08) | 8.28 | (6.13) | 20.28 |
Trevi Therapeutics Additional Predictive Modules
Most predictive techniques to examine Trevi price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Trevi using various technical indicators. When you analyze Trevi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Trevi Therapeutics Predictive Indicators
The successful prediction of Trevi Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Trevi Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Trevi Therapeutics based on analysis of Trevi Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Trevi Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Trevi Therapeutics's related companies. | 2025 | 2026 (projected) | Payables Turnover | 0.021 | 0.019 | Days Of Inventory On Hand | 19.9K | 17.7K |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for Trevi Stock analysis
When running Trevi Therapeutics' price analysis, check to measure Trevi Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trevi Therapeutics is operating at the current time. Most of Trevi Therapeutics' value examination focuses on studying past and present price action to predict the probability of Trevi Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trevi Therapeutics' price. Additionally, you may evaluate how the addition of Trevi Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |